Microbiome and Cancer Immunotherapies

Authors

Haoyan Chen
Laurence Zitvogel
Zhi Peng
Xiaochen Yin
Florencia McAllister

Publication Date

4-16-2024

Journal

Cell Reports Medicine

Abstract

Here, we present 3 different perspectives on how the microbiome has impacted cancer patients, treatment, and clinical studies. We hear about the challenges of implementing microbiome analyses into the clinics, the impact these analyses might have on patients' care, and treatment in the future, specifically for gastric cancer treatment. These are a few of the many voices that are highlighting the role of the microbiome in cancer development, treatment, and clinical outcomes.

Keywords

Humans, Microbiota, Immunotherapy, Stomach Neoplasms

Comments

PMID: 38631286

DOI

10.1016/j.xcrm.2024.101514

PMID

38631286

PMCID

PMC11031416

PubMedCentral® Posted Date

April 2024

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes